產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ESYT1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ESYT1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ESYT1
Cat. Number:
Anti-ESYT1抗體KL-11002R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Encoding over 1,100 genes within 132 million bases, chromosome 12 makes up about 4.5% of the human genome. A number Anti-ESYT1抗體of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, achondrogenesis and Kniest dysplasia. Noonan syndrome, which includes heart and facial developmental defects among the primary symptoms, is caused by a mutant form of PTPN11 gene product, SH-PTP2. Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction. Trisomy 12p leads to facial development defects, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy. The FAM62A gene product has been provisionally designated FAM62A pending further characterization.
Also known as:
Extended synaptotagmin 1;Anti-ESYT1抗體 KIAA0747; E Syt1; E-Syt1; Esyt1; ESYT1_HUMAN; Extended synaptotagmin like protein 1; Extended synaptotagmin-1; Family with sequence similarity 62 (C2 domain containing) member A; Family with sequence similarity 62 member A; MBC2; Membrane bound C2 domain containing protein; Membrane-bound C2 domain-containing protein; Protein FAM62A.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Monkey, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ESYT1/FA.
●
Predicted Molecular Weight:Anti-ESYT1抗體 123kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-ESYT1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ESYT1抗體
Optimal working dilutions must be determined by the end user.
kl079Rb52 白介素6(IL6)多克隆抗體 Polyclonal Antibody to Interleukin 6 (IL6)
kl079Si01 白介素6(IL6)多克隆抗體 Polyclonal Antibody to Interleukin 6 (IL6)
kl081Ga01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Hu01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Mu01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Ra01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl081Si01 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl083Hu01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Mu01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Po01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Ra01 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl085Bo01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Ca01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Cp01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Hu01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Mu01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Po01 白血病抑制因子(LIF)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
